Company
Cardior Pharmaceuticals
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
A leading clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease. Acquired by Novo Nordisk in March 2024.
About the company
- Status notes
- Acquired by Novo Nordisk in March 2024.
Exit
- Acquisition
- 2024-03
Loading relationship preview